サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1547534

経口薄膜の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Oral Thin Films Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 170 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
経口薄膜の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 170 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

経口薄膜市場の世界需要は、2023年の39億9,000万米ドルから2032年には92億9,000万米ドル近くの市場規模に達すると推定され、調査期間2024～2032年のCAGRは9.85%です。

経口薄膜は、ドラッグデリバリーに使用される薄く柔軟なフィルムで、口腔粘膜で溶解するため、薬剤の作用発現が早く、バイオアベイラビリティが向上します。経口薄膜は主に、固形の薬剤を摂取できない高齢者、小児、寝たきりの患者に使用されます。そのため、製薬会社は既存の医薬品を溶解速度の速い経口薄膜医薬品に切り替えるため、目覚ましい研究開発を行っています。また、経口薄膜製剤の用途は頬部用製剤にとどまらず、胃内投与用製剤や舌下投与用製剤にも広がっています。そのため、製薬業界は医薬品開発期間の短縮と効率的なドラッグデリバリー・プラットフォームに注力しています。さらに、効率的なドラッグデリバリー技術と薬剤の輸送における利便性への需要が高まっており、これが最近の市場を活性化しています。

市場力学

経口薄膜は親水性ポリマーで構成され、舌や頬腔で素早く溶解し、液体と接触すると溶解を介して薬剤を全身循環に送り込みます。経口薄膜にはいくつかの利点があります。即効性、輸送の容易さ、肝初回通過効果の回避、ハンドリングなどです。さらに、これらは薬剤の高いバイオアベイラビリティと迅速な吸収を記載しています。したがって、舌下経口薄膜製剤は、迅速な緩和のための完全なドラッグデリバリーを提供するため、錠剤のより良い代替品です。その上、嚥下困難者は薬剤の経口投与を必要とします。そのため、経口薄膜薬は迅速な経口投与のために開発されました。患者のコンプライアンスを向上させるため、様々な種類のワクチンやホルモン剤が市場メーカーによって開発されています。酸に弱い薬剤の胃腸での分解を防ぐための経口薄膜の使用は、世界市場を牽引すると考えられます。しかし、経口薄膜を含む治療には高額な費用がかかること、莫大な研究投資が必要なこと、薬剤開発に関する課題があることが、世界レベルでの市場成長の妨げとなっています。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは経口薄膜の世界市場における各セグメントを包括的に評価することもできます。経口薄膜産業の成長と動向は、この調査に全体的なアプローチを記載しています。

市場セグメンテーション

経口薄膜市場レポートのこのセクションでは、国別と地域別のセグメントに関する詳細なデータを提供し、それによって戦略家が今後のビジネス機会とともに、それぞれの製品やサービスの対象層を特定するのに役立ちます。

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける経口薄膜市場の現在と将来の需要を強調する地域展望をカバーします。さらに、著名な全地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。

特注のご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 経口薄膜-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカー一覧
    • 主要原材料の価格動向
  • 潜在的バイヤー一覧
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 経口薄膜の世界市場分析：製品別

  • 製品別概要
  • 製品別過去・予測データ分析
  • 舌下フィルム
  • 口腔用速溶フィルム
  • バッカルフィルム

第6章 経口薄膜の世界市場分析：適応症別

  • 適応症別概要
  • 適応症別過去・予測データ分析
  • 疼痛管理
  • 神経疾患
  • 吐き気・嘔吐
  • オピオイド依存症
  • その他

第7章 経口薄膜の世界市場分析：流通チャネル別

  • 流通チャネル別概要
  • 流通チャネル別過去・予測データ分析
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第8章 経口薄膜の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第9章 経口薄膜企業の競合情勢

  • 経口薄膜市場の競合
  • 提携・協力・契約
  • 合併・買収
  • 新製品の上市
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Aquestive Therapeutics Inc.
  • C.L. Pharm
  • Cure Pharmaceutical
  • Dr. Reddy'S Laboratories
  • Indivior Plc
  • IntelGenx Corp.
  • Kyu Kyu Pharmaceutical Co. Ltd.
  • DK Livkon Pvt. Ltd.
  • NAL Pharma
  • Seoul Pharma Co. Ltd.
  • Shilpa Therapeutics Pvt. Ltd.
  • Sunovion Pharmaceuticals Inc.
  • ZIM Laboratories Limited
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Sublingual Film Market Sales By Geography (USD MN)
  • Fast-dissolving Oral Film Market Sales By Geography (USD MN)
  • Buccal Film Market Sales By Geography (USD MN)
  • Analysis By Indication (USD MN)
  • Pain Management Market Sales By Geography (USD MN)
  • Neurological Disorders Market Sales By Geography (USD MN)
  • Nausea & Vomiting Market Sales By Geography (USD MN)
  • Opioid Dependence Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Oral Thin Films Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Oral Thin Films Report
  • Market Research Process
  • Market Research Methodology
  • Global Oral Thin Films Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Indication
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Sublingual Film Market Sales By Geography (USD MN)
  • Fast-dissolving Oral Film Market Sales By Geography (USD MN)
  • Buccal Film Market Sales By Geography (USD MN)
  • Global Market Analysis By Indication (USD MN)
  • Pain Management Market Sales By Geography (USD MN)
  • Neurological Disorders Market Sales By Geography (USD MN)
  • Nausea & Vomiting Market Sales By Geography (USD MN)
  • Opioid Dependence Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11215033

The global demand for Oral Thin Films Market is presumed to reach the market size of nearly USD 9.29 Billion by 2032 from USD 3.99 Billion in 2023 with a CAGR of 9.85% under the study period 2024-2032.

Oral thin films are thin, flexible films used for drug delivery that dissolve in the oral mucosa resulting in the rapid onset of action and enhanced bioavailability for drugs. The oral thin films are mainly used for geriatric, pediatric, and bedridden patients who cannot intake the solid form of the medicine. Therefore, the pharmaceutical companies are carrying out remarkable R&D to switch their existing drugs in the fast dissolving oral thin films drugs. Moreover, the application of oral thin films is not limited to buccal systems but also expands in the applications of gastroretentive and sublingual delivery systems. Therefore, the pharmaceutical industry is concentrating on shortening drug development timelines and efficient drug delivery platforms. Moreover, there is a growing demand for efficient drug delivery techniques and convenience in the transportation of the drug, which has fuelled the market in the recent past.

MARKET DYNAMICS

The oral film is made up of hydrophilic polymers that quickly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made. Oral thin films have several advantages: the fast onset of action, ease of transportation, bypassing hepatic first-pass effect, and handling. In addition, these offer high bioavailability and rapid absorption for drugs. Therefore, the sublingual oral thin film is a better alternative for tablets, as it provides complete drug delivery for quick relief. Besides, people with swallowing difficulty require oral administration of drugs. Therefore, oral thin film medication is developed for swift oral administration of medicines. To improve patient compliance, various types of vaccines and hormones are developed by the market players. The use of oral thin films for preventing gastrointestinal degradation of acid-sensitive drugs will drive the global market. However, the expensive cost of treatments involving oral thin films, the requirement of vast research investment, and challenges related to drug development are hampering the market growth at the global level.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Oral Thin Films. The growth and trends of Oral Thin Films industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Oral Thin Films market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Sublingual Film
  • Fast-dissolving Oral Film
  • Buccal Film

By Indication

  • Pain Management
  • Neurological Disorders
  • Nausea & Vomiting
  • Opioid Dependence
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Oral Thin Films market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Oral Thin Films market include Aquestive Therapeutics Inc., C.L. Pharm, Cure Pharmaceutical, Dr. Reddy'S Laboratories, Indivior Plc, IntelGenx Corp., Kyu Kyu Pharmaceutical Co. Ltd., DK Livkon Pvt. Ltd., NAL Pharma, Seoul Pharma Co. Ltd., Shilpa Therapeutics Pvt. Ltd., Sunovion Pharmaceuticals Inc., ZIM Laboratories Limited. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ORAL THIN FILMS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Indication
    • 3.7.3 Market Attractiveness Analysis By Distribution Channel
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ORAL THIN FILMS MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Sublingual Film Historic and Forecast Sales By Regions
  • 5.4. Fast-dissolving Oral Film Historic and Forecast Sales By Regions
  • 5.5. Buccal Film Historic and Forecast Sales By Regions

6. GLOBAL ORAL THIN FILMS MARKET ANALYSIS BY INDICATION

  • 6.1. Overview By Indication
  • 6.2. Historical and Forecast Data Analysis By Indication
  • 6.3. Pain Management Historic and Forecast Sales By Regions
  • 6.4. Neurological Disorders Historic and Forecast Sales By Regions
  • 6.5. Nausea & Vomiting Historic and Forecast Sales By Regions
  • 6.6. Opioid Dependence Historic and Forecast Sales By Regions
  • 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL ORAL THIN FILMS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 7.1. Overview By Distribution Channel
  • 7.2. Historical and Forecast Data Analysis By Distribution Channel
  • 7.3. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 7.4. Retail Pharmacies Historic and Forecast Sales By Regions
  • 7.5. Online Pharmacies Historic and Forecast Sales By Regions

8. GLOBAL ORAL THIN FILMS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ORAL THIN FILMS COMPANIES

  • 9.1. Oral Thin Films Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF ORAL THIN FILMS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Aquestive Therapeutics Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. C.L. Pharm
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Cure Pharmaceutical
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Dr. Reddy'S Laboratories
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Indivior Plc
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. IntelGenx Corp.
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Kyu Kyu Pharmaceutical Co. Ltd.
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. DK Livkon Pvt. Ltd.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. NAL Pharma
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Seoul Pharma Co. Ltd.
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Shilpa Therapeutics Pvt. Ltd.
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Sunovion Pharmaceuticals Inc.
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. ZIM Laboratories Limited
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies